Suppr超能文献

脂联素的血清和支气管肺泡灌洗水平在晚期非小细胞肺癌中的预后价值

The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer.

作者信息

Boura Paraskevi, Grapsa Dimitra, Loukides Stylianos, Angelidou Maria, Tsakanika Konstantina, Syrigos Nikolaos, Gkiozos Ioannis

机构信息

Oncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.

3rd Pulmonary Department, Sismanoglio General Hospital, 15126, Athens, Greece.

出版信息

Lung Cancer Manag. 2017 Nov;6(2):55-65. doi: 10.2217/lmt-2016-0018. Epub 2017 Nov 17.

Abstract

AIM

We aimed to explore the prognostic implications of adiponectin (APN) levels in the serum and bronchoalveolar lavage (BAL) of patients with advanced NSCLC.

MATERIALS & METHODS: 29 newly diagnosed patients with stage IV NSCLC were prospectively enrolled. Baseline serum and BAL levels of APN were assayed by ELISA and correlated with various clinicopathological parameters, including overall survival.

RESULTS

No statistically significant correlations were observed between the serum or BAL levels of APN and the clinicopathological parameters evaluated. The only prognostic factor identified, both by univariate and multivariate survival analyses, was performance status.

CONCLUSION

The results of our cohort failed to reveal any prognostic significance of serum and BAL levels of APN in stage IV NSCLC.

摘要

目的

我们旨在探讨晚期非小细胞肺癌(NSCLC)患者血清和支气管肺泡灌洗(BAL)中脂联素(APN)水平的预后意义。

材料与方法

前瞻性纳入29例新诊断的IV期NSCLC患者。采用酶联免疫吸附测定(ELISA)法检测APN的基线血清和BAL水平,并将其与包括总生存期在内的各种临床病理参数相关联。

结果

未观察到APN的血清或BAL水平与所评估的临床病理参数之间存在统计学显著相关性。单因素和多因素生存分析确定的唯一预后因素是体能状态。

结论

我们队列的结果未能揭示IV期NSCLC患者血清和BAL中APN水平的任何预后意义。

相似文献

1
The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer.
Lung Cancer Manag. 2017 Nov;6(2):55-65. doi: 10.2217/lmt-2016-0018. Epub 2017 Nov 17.
2
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment.
Immunobiology. 2020 Sep;225(5):151997. doi: 10.1016/j.imbio.2020.151997. Epub 2020 Aug 1.
4
Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: prognostic correlation.
Med Oncol. 2009;26(2):161-6. doi: 10.1007/s12032-008-9102-y. Epub 2008 Dec 18.
5
Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Tumour Biol. 2016 Feb;37(2):1949-58. doi: 10.1007/s13277-015-3994-x. Epub 2015 Sep 3.

引用本文的文献

本文引用的文献

3
Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
Am J Epidemiol. 2014 Jul 1;180(1):11-4. doi: 10.1093/aje/kwu124. Epub 2014 Jun 10.
4
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.
Lancet Respir Med. 2013 May;1(3):251-61. doi: 10.1016/S2213-2600(13)70009-2. Epub 2013 Mar 1.
5
Role of adiponectin and its receptors in cancer.
Cancer Biol Med. 2012 Dec;9(4):213-20. doi: 10.7497/j.issn.2095-3941.2012.04.001.
6
Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1.
Int J Biochem Cell Biol. 2013 Jun;45(6):1145-53. doi: 10.1016/j.biocel.2013.03.003. Epub 2013 Mar 15.
7
Clinical significance of serum adipokines levels in lung cancer.
Med Oncol. 2013 Jun;30(2):507. doi: 10.1007/s12032-013-0507-x. Epub 2013 Feb 22.
8
Molecular pathways: adiponectin and leptin signaling in cancer.
Clin Cancer Res. 2013 Apr 15;19(8):1926-32. doi: 10.1158/1078-0432.CCR-12-0930. Epub 2013 Jan 25.
9
Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Cytokine. 2013 Feb;61(2):532-9. doi: 10.1016/j.cyto.2012.10.023. Epub 2012 Nov 27.
10
The role of adiponectin in cancer: a review of current evidence.
Endocr Rev. 2012 Aug;33(4):547-94. doi: 10.1210/er.2011-1015. Epub 2012 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验